Supportive care for patients with early breast cancer

• Autores: Laura G. García Estévez, Ignacio Tusquets Trias de Bes, Isabel Álvarez, César Augusto Rodríguez Sánchez, Miguel Ángel Seguí Palmer, Jesús García Mata, Ana Lluch Hernández
• Localización: Clinical & translational oncology, ISSN 1699-048X, Vol. 12, Nº. 1, 2010, págs. 32-42
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • Breast cancer treatment currently requires the joint efforts of a multidisciplinary team to effectively combine chemotherapy, hormone therapy, biological agents, surgery and radiation therapy when needed. To develop such a treatment plan, it is important to know the benefits as well as the potencial toxic effects of each therapy. Thus, many patients with early breast cancer complain of collateral adverse events such as fatigue, nausea, vomiting, loss of libido, hot flashes, night sweats or neurophaty due to the complex therapies they are receiving. To date, the treatment of such symptoms is an important issue that greatly affects the quality of life of these patients. In this review, we report the content of a multi-expert meeting where the incidence of and medical approach to some of the most common adverse events encountered during the treatment of patients with early breast cancer were analysed.